{"nctId":"NCT00127673","briefTitle":"Comparison of Two Treatments for Post-Traumatic Stress Disorder","startDateStruct":{"date":"2004-09"},"conditions":["Post-Traumatic Stress Disorder"],"count":200,"armGroups":[{"label":"CBT no choice","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Cognitive behavioral therapy (CBT)"]},{"label":"CBT choice","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Cognitive behavioral therapy (CBT)"]},{"label":"sertraline no choice","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sertraline"]},{"label":"sertraline choice","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sertraline"]}],"interventions":[{"name":"Sertraline","otherNames":["Zoloft"]},{"name":"Cognitive behavioral therapy (CBT)","otherNames":["Prolonged exposure (PE)"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* DSM-IV diagnosis of PTSD\n* Experienced traumatic event at least 12 weeks prior to study entry\n* Willingness to discontinue current CBT or antidepressant treatment\n\nExclusion Criteria:\n\n* Current diagnosis of schizophrenia or delusional disorder\n* Medically unstable bipolar disorder, depression with psychotic features, or depression requiring psychiatric treatment\n* Current diagnosis of alcohol or substance dependence within 3 months prior to study entry\n* Ongoing intimate relationship with the perpetrator of the traumatic event\n* History of nonresponse to either CBT or sertraline\n* Medical contraindication for sertraline","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"PTSD Symptoms","description":"total score, range from 0-80, higher scores are more severe","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.02","spread":"10.27"},{"groupId":"OG001","value":"10.87","spread":"8.75"},{"groupId":"OG002","value":"15.12","spread":"14.03"},{"groupId":"OG003","value":"10.78","spread":"7.59"}]}]}]},{"type":"PRIMARY","title":"Depression Symptoms","description":"Hamilton Depression Rating Scale (HAMD), total score, scoring range 0-50, with higher scores more severe depression","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.33","spread":"10.33"},{"groupId":"OG001","value":"12.13","spread":"8.67"},{"groupId":"OG002","value":"15.24","spread":"13.90"},{"groupId":"OG003","value":"12.11","spread":"10.12"}]}]}]},{"type":"PRIMARY","title":"State Anxiety","description":"State-Trait Anxiety Inventory - State version, total score, scoring range, 0-63, with higher scores more severe","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.16","spread":"13.83"},{"groupId":"OG001","value":"38.79","spread":"13.13"},{"groupId":"OG002","value":"46.89","spread":"18.91"},{"groupId":"OG003","value":"38.72","spread":"12.48"}]}]}]},{"type":"SECONDARY","title":"Quality of Life Functioning","description":"Sheehan Disability Scale (SDS), total score, scoring range 0-30 , higher scores indicative of worse functional impairment","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.82","spread":"6.24"},{"groupId":"OG001","value":"11.68","spread":"8.23"},{"groupId":"OG002","value":"14.06","spread":"10.38"},{"groupId":"OG003","value":"10.78","spread":"9.40"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":48},"commonTop":["Gastrointestinal discomfort","Headache/dizziness","Transient increased in agitation/anxiety","Delayed ejaculation","Urinary hesitancy"]}}}